Improving the survival of grafted dopaminergic neurons: A review over current approaches

Cell Transplantation

Volumn 9, Issue 2, 2000, Pages 179-195

  Brundin, Patrik ^a   Karlsson, Jenny ^a   Emgård, Mia ^a   Kaminski Schierle, Gabriele S ^a   Hansson, Oskar ^a   Petersén, Åsa ^a   Castilho, Roger F ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cell death; Growth factor; Neuroprotection; Parkinson's disease; Transplantation

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; 2,4 DIAMINOPYRROLOPYRIMIDINE; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ADENOSINE TRIPHOSPHATE; BASIC FIBROBLAST GROWTH FACTOR; CALCIUM; CASPASE; CASPASE INHIBITOR; CATALASE; CYTOCHROME C OXIDASE; DIZOCILPINE; DNA FRAGMENT; DOPAMINE; EXCITATORY AMINO ACID; FLUNARIZINE; FREE RADICAL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE PEROXIDASE; GROWTH FACTOR; LAZAROID; NIMODIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE; PROTEINASE; PYRROLOPYRIMIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TIRILAZAD; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; GRAFT SURVIVAL; HUMAN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSPLANTATION;

EID: 0034065380     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900205     Document Type: Article

References (151)

1. Adams, J. M.; Cory, S. The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326; 1998.
2. Akaike, N.; Kostyuk, P. G.; Osipchuk, Y. V. Dihydropyridine-sensitive low-threshold calcium channels in isolated hypothalamic neurones. J. Physiol. (Lond.) 412: 181-195; 1989.
3. Ankarcrona, M.; Dypbukt, J. M.; Bonfoco, E.; Zhivotovsky, B.; Orrenius, S.; Lipton, S. A.; Nicotera, P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973; 1995.
4. Apostolides, C.; Sanford, E.; Hong, M.; Mendez, I. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363-372; 1998.
5. Azbill, R. D.; Mu, X.; Bruce-Keller, A. J.; Mattson, M. P.; Springer, J. E. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 765: 283-290; 1997.
6. Barbin, G.; Mallat, M.; Prochiantz, A. In vitro studies on the maturation of mesencephalic dopaminergic neurons. Dev. Neurosci. 7:296-307; 1985.
7. Barkats, M.; Nakao, N.; Grasbon-Frodl, E. M.; Bilang-Bleuel, A.; Revah, F.; Mallet, J.; Brundin, P. Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase. Neuroscience 78:703-713; 1997.
8. Barker, R. A.; Dunnett, S. B.; Faissner, A.; Fawcett, J. W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141:79-93; 1996.
9. Barker, R. A.; Fricker, R. A.; Abrous, D. N.; Fawcett, J.; Dunnett, S. B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 4:173-200; 1995.
10. Beyer, C.; Pilgrim, C.; Reisert, I. Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: Sex differences and effects of sex steroids. J. Neurosci. 11:1325-1333; 1991.
11. Björklund, A.; Lindvall, O. Dopamine-containing systems in the CNS. In: Björklund, A.; Hökfelt, T.; Kuhr, M. J., eds. Handbook of chemical neuroanatomy, vol. 2. Amsterdam: Elsevier Science Publishers; 1984:55-122.
12. Björklund, A.; Stenevi, U.; Schmidt, R. H.; Dunnett, S. B.; Gage, F. H. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. 522:1-7; 1983.
13. Björklund, L.; Spenger, C.; Strömberg, I. Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model. Exp. Neurol. 148:324-333; 1997.
14. Braughler, J. M.; Hall, E. D.; Jacobsen, E. J.; McCall, J. M.; Means, E. D. The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14:143-152; 1989.
15. Bredesen, D. E. Neural apoptosis. Ann. Neurol. 38:839-851; 1995.
16. Brundin, P.; Björklund, A. Survival, growth and function of dopaminergic neurons grafted to the brain. Prog. Brain Res. 71:293-308; 1987.
17. Brundin, P.; Björklund, A.; Lindvall, O. Practical aspects of the use of human fetal brain tissue for intracerebral grafting. Prog. Brain Res. 82:707-714; 1990.
18. Brundin, P.; Duan, W.-M.; Sauer, H. Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Dunnett, S. B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:9-46.
19. Brundin, P.; Isacson, O.; Björklund, A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:251-259; 1985.
20. Brundin, P.; Isacson, O.; Gage, F. H.; Björklund, A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cells. Dev. Brain Res. 24:77-84; 1986.
21. Brundin, P.; Petersén, A.; Hansson, O. Graft survival. J. Neurosurg. 90:188-189; 1999.
22. Brundin, P.; Strecker, R. E. Preparation and intracerebral grafting of dissociated fetal brain tissue in rats. In: Conn, P. M., ed. Methods in neurosciences, vol. 7 - lesions and transplantation. New York: Academic Press; 1991:305-326.
23. Brundin, P.; Strecker, R. E.; Widner, H.; Clarke, D. J.; Nilsson, O. G.; Åstedt, B.; Lindvall, O.; Björklund, A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain. Res. 70:192-208; 1988.
24. Burke, R. E.; Antonelli, M.; Sulzer, D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J. Neurochem. 71:517-525; 1998.
25. Cacalano, G.; Farinas, I.; Wang, L. C.; Hagler, K.; Forgie, A.; Moore, M.; Armanini, M.; Phillips, H.; Ryan, A. M.; Reichardt, L. F.; Hynes, M.; Davies, A.; Rosenthal, A. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21:53-62; 1998.
26. Cao, X.; Phillis, J. W. α-phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644:267-272; 1994.
27. Castilho, R. F.; Hansson, O.; Ward, M. W.; Budd, S. L.; Nicholls, D. G. Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurosci. 18:10277-10286; 1998.
28. Chan, P. K. Role of oxidants in ischemic brain damage. Stroke 27:1124-1129; 1996.
29. Clarkson, E. D.; Zawada, W. M.; Freed, C. R. GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport 7:145-149; 1995.
30. Colton, C. A.; Gilbert, D. L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 223:284-288; 1987.
31. Costantini, L. C.; Vozza, B. M.; Snyder-Keller, A. M. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats. Exp. Neurol. 127:219-231; 1994.
32. Coyle, J. T.; Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695; 1993
33. Day, B. J.; Fridovich, I.; Crapo, J. D. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch. Biochem. Biophys. 347:256-262; 1997.
34. de Bilbao, F.; Dubois-Dauphin, M. Acute application of an interleukin-1 beta-converting enzyme-specific inhibitor delays axotomy-induced motoneurone death. Neuroreport 25:3051-3054; 1996.
35. Deckwerth, T. L.; Johnson, E. M., Jr. Neurotrophic factor deprivation-induced death. Ann. NY Acad. Sci. 679: 121-131; 1993.
36. Deshmukh, M.; Johnson, E. M., Jr. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 21:695-705; 1998.
37. Duan, W.-M.; Widner, H.; Brundin, P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp. Brain. Res. 104:227-242; 1995.
38. Dubois-Dauphin, M.; Frankowski, H.; Tsujimoto, Y.; Huarte, J.; Martinou, J.-C. Neonatal motorneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA 91:3309-3313; 1994.
39. Eichler, M. E.; Dubinsky, J. M.; Tong, J.; Rich, K. M. The ability of diphenylpiperazines to prevent neuronal death in dorsal root ganglion neurons in vitro after nerve growth factor deprivation and in vivo after axotomy. J. Neurochem. 62:2148-2157; 1994.
40. Elimadi, A.; Bouillot, L.; Sapena, R.; Tillement, J. P.; Morin, D. Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition. Eur. J. Pharmacol. 348:115-121; 1998.
41. Emgård, M.; Castilho, R. F.; Brundin, P. Catalase and Mn(III) tetrakis (4-benzoic acid) porphyrin decrease death of grafted dopaminergic neurons. Soc. Neurosci. Abstr. 25:294.9; 1999.
42. Emgård, M.; Karlsson, J.; Hansson, O.; Brundin, P. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp. Neurol. 160:279-288; 1999.
43. Emgård-Mattson, M.; Karlsson, J.; Nakao, N.; Brundin, P. Addition of lateral ganglionic eminence to rat mesencephalic grafts affects fiber outgrowth but does not enhance function. Cell Transplant. 6:277-286; 1997.
44. Emmett, C. J.; Jaques-Berg, W.; Seeley, P. J. Microtransplantation of neural cells into adult rat brain. Neuroscience 38:213-222; 1990.
45. Engele, J. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons. J. Neurosci. Res. 53:405-414; 1998.
46. Engele, J.; Bohn, M. C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11: 3070-3078; 1991.
47. Farlie, P. G.; Dringen, R.; Rees, S. M.; Kannourakis, G.; Bernard, O. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. USA 92:4397-4401; 1995.
48. Faulkner, K. M.; Liochev, S. I.; Fridovich, I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 269:23471-23476; 1994.
49. Fawcett, J. W.; Barker, R. A.; Dunnett, S. B. Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp. Brain Res. 106:275-282; 1995.
50. Ferrari, G.; Minozzi, M. C.; Toffano, G.; Leon, A.; Skaper, S. D. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133:140-147; 1989.
51. Fici, G. J.; Althaus, J. S.; VonVoigtlander, P. F. Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicity. Free Radic. Biol. Med. 22:223-228; 1997.
52. Finger, S.; Dunnett, S. B. Nimodipine enhances growth factor vascularization of neural grafts. Exp. Neurol. 104: 1-9; 1989.
53. Floyd, R. A.; Carney, J. M. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32:S22-S27; 1992.
54. Frodl, E. M.; Duan, W. M.; Sauer, H.; Kupsch, A.; Brundin, P. Human embryonic dopamine neurons xenografted to the rat: Effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647:286-298; 1994.
55. Frodl, E. M.; Nakao, N.; Brundin, P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport 5:2393-2396; 1994.
56. German, D. C.; Schlusselberg, D. S.; Woodward, D. J. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: From mouse to man. J. Neural. Transm. 57:243-254; 1983.
57. Ghirnikar, R. S.; Lee, Y. L.; Eng, L. F. Inflammation in traumatic brain injury: Role of cytokines and chemokines. Neurochem. Res. 23:329-340; 1998.
58. Glozman, S.; Yavin, E. Lipid peroxides are generated by the fetal rat brain after episodes of global ischemia in utero. Neurochem. Res. 22:201-208; 1997.
59. Granholm, A. C.; Mott, J. L.; Bowenkamp, K.; Eken, S.; Henry, S.; Hoffer, B. J.; Lapchak, P. A.; Palmer, M. R.; van Horne, C.; Gerhardt, G. A. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain. Res. 116:29-38; 1997.
60. Grasbon-Frodl, E. M.; Andersson, A.; Brundin, P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67:1653-1660; 1996.
61. Grasbon-Frodl, E. M.; Brundin, P. Mesencephalic neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U-83836E. Exp. Brain Res. 113: 138-143; 1997.
62. Grasbon-Frodl, E. M.; Nakao, N.; Brundin, P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39:341-347; 1996.
63. Green, D. R. Apoptotic pathways: The roads to ruin. Cell 94:695-698; 1998.
64. Hagell, P.; Schrag, A.; Piccini, P.; Jahanshahi, M.; Brown, R.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J. C.; Odin, P.; Wenning, G. K.; Morrish, P.; Gustavii, B.; Björklund, A.; Brooks, D. J.; Marsden, C. D.; Quinn, N. P.; Lindvall, O. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122:1121-1132; 1999.
65. Hall, E. D. Lipid antioxidant neuroprotectants for acute and chronic neurodegenerative disorders. In: Bär, P. R.; Beal, M. F., eds. Neuroprotection in CNS diseases. New York: Marcel Dekker Inc.; 1997:161-181.
66. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1609-1623; 1992.
67. Haque, N. S.; Hlavin, M. L.; Du, J. S.; Fawcett, J. W.; Dunnett, S. B. In vivo effects of kFGF on embryonic nigral grafts in a rat model of Parkinson's disease. Neuroreport 6:2177-2181. 1995.
68. Haque, N. S.; Hlavin, M. L.; Fawcett, J. W.; Dunnett, S. B. The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Brain Res. 712:45-52; 1996.
69. Hara, H.; Friedlander, R. M.; Gagliardini, V.; Ayata, C.; Fink, K.; Huang, Z.; Shimizu-Sasamata, M.; Yuan, J.; Moskowitz, M. A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94:2007-2012; 1997.
70. Hedreen, J. C.; Chalmers, J. P. Neuronal degeneration in rat brain induced by 6-hydroxydopamine: A histological and biochemical study. Brain Res. 47:1-30; 1972.
71. Heizmann, C. W.; Hunziker, W. Intracellular calcium-binding proteins: More sites than insights. Trends Biochem. Sci. 16:98-103; 1991.
72. Horger, B. A.; Nishimura, M. C.; Armanini, M. P.; Wang, L. C.; Poulsen, K. T.; Rosenblad, C.; Kirik, D.; Moffat, B.; Simmons, L.; Johnson, E., Jr.; Milbrandt, J.; Rosenthal, A.; Björklund, A.; Vandlen, R. A.; Hynes, M. A.; Phillips, H. S. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18:4929-4937; 1998.
73. Hyman, C.; Hofer, M.; Barde, Y. A.; Juhasz, M.; Yancopoulos, G. D.; Lindsay, R. M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232; 1991.
74. Hyman, C.; Juhasz, M.; Jackson, C.; Wright, P.; Ip, N. Y.; Lindsay, R. M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:335-347; 1994.
75. Janec, E.; Burke, R. E. Naturally occurring cell death during postnatal development in the substantia nigra pars compacta of rat. Mol. Cell. Neurosci. 4:30-35; 1993.
76. Jenner, P.; Olanow, C. W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47: S161-170; 1996.
77. Kaminski Schierle, G. S.; Hansson, O.; Brundin, P. Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience 94:17-20; 1999.
78. Karlsson, J.; Emgård, M.; Rosenblad, C.; Brundin, P. Treatment with the spin-trap agent α-phenyl-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. Brain Res. 805:155-168; 1998.
79. Karlsson, J.; Love, R.; Clarke, D. J.; Brundin, P. Effects of euthanasia and lazaroids on survival of grafted dopaminergic neurones. Brain Res. Interact. (in press).
80. Klann E. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J. Neurophysiol. 80:452-457; 1998.
81. Kordower, J. H.; Freeman, T. B.; Chen, E. Y.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Snow, B.; Olanow, C. W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13:383-393; 1998.
82. Kordower, J. H.; Rosenstein, J. M.; Collier, T. J.; Burke, M. A.; Chen, E. Y.; Li, J. M.; Martel, L.; Levey, A. E.; Mufson, E. J.; Freeman, T. B.; Olanow, C. W. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 24:203-230; 1996.
83. Kotzbauer, P. T.; Lampe, P. A.; Heuckeroth, R. O.; Golden, J. P.; Creedon, D. J.; Johnson, E. M., Jr.; Milbrandt, J. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384:467-470; 1996.
84. Kroemer, G.; Dallaporta, B.; Resche-Rigon, M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619-642; 1998.
85. Leist, M.; Nicotera, P. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239:183-201; 1998.
86. Leist, M.; Nicotera, P. Calcium and neuronal death. Rev. Physiol. Biochem. Pharmacol. 132:79-125; 1998.
87. Lin, L. F.; Doherty, D. H.; Lile, J. D.; Bektesh, S.; Collins, F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132; 1993.
88. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C.; Marsden, C. D.; Björklund, A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577; 1990.
89. Lynch, D. R.; Dawson, T. M. Secondary mechanisms in neuronal trauma. Curr. Opin. Neurol. 7:510-516; 1994.
90. Mahalik, T. J.; Hahn, W. E.; Clayton, G. H.; Owens, G. P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:27-36; 1994.
91. Martinou, J.-C.; Dubois-Dauphin, M.; Staple, J. K.; Rodriguez, I.; Frankowski, H.; Missotten, M.; Albertini, P.; Talabot, D.; Catsicas, S.; Pietra, C.; Huarte, J. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030; 1994.
92. Mattson, M. P. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21:53-57; 1998.
93. Mayer, E.; Dunnett, S. B.; Fawcett, J. W. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons - II. Effects on nigral transplants in vivo. Neuroscience 56:389-398; 1993.
94. McEnery, M. W.; Vance, C. L.; Begg, C. M.; Lee, W. L.; Choi, Y.; Dubel, S. J. Differential expression and association of calcium channel subunits in development and disease. J. Bioenerg. Biomembr. 30:409-418; 1998.
95. McIntosh, T. K. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. J. Neurotrauma 10:215-261; 1993.
96. Mehta, V.; Hong, M.; Spears, J.; Mendez, I. Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J. Neurosurg. 88:1088-1095; 1998.
97. Milligan, C. E.; Prevette, D.; Yaginuma, H.; Homma, S.; Cardwell, C.; Fritz, L. C.; Tomaselli, K. J.; Oppenheim, R. W.; Schwartz, L. M. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15:385-393; 1995.
98. Nakao, N.; Frodl, E. M.; Duan, W.-M.; Widner, H.; Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91:12408-12412; 1994.
99. Nakao, N.; Frodl, E. M.; Widner, H.; Carlson, E.; Eggerding, F. A.; Epstein, C. J.; Brundin, P. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:226-231; 1995.
100. Nakao, N.; Grasbon-Frodl, E. M.; Widner, H.; Brundin, P. Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 73:185-200; 1996.
101. Nikkhah, G.; Eberhard, J.; Olsson, M.; Björklund, A. Preservation of fetal ventral mesencephalic cells by cool storage: In-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res. 687:22-34; 1995.
102. Nikkhah, G.; Olsson, M.; Eberhard, J.; Bentlage, C.; Cunningham, M. G.; Björklund, A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: A detailed account of the methodology. Neuroscience 63:57-72; 1994.
103. Offen, D.; Beart, P. M.; Cheung, N. S.; Pascoe, C. J.; Hochman, A.; Gorodin, S.; Melamed, E.; Bernard, R.; Bernard, O. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl. Acad. Sci. USA 95:5789-5794; 1998.
104. Olanow, C. W. An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 32(Suppl.): S2-9; 1992.
105. Oliver, C. N.; Starke-Reed, P. E.; Stadtman, E. R.; Liu, G. J.; Carney, J. M.; Floyd, R. A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87:5144-5147; 1990.
106. Olney, J. W. Neurotoxicity of excitatory amino acids. In: McGeer, E. G.; Olney, J. W.; McGeer, P. L., eds. Kainic acid as a tool in neurobiology. New York: Raven Press; 1978:95-121.
107. Oppenheim, R. W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453-501; 1991.
108. 2+ in toxic cell killing. Trends Pharmacol. Sci. 10:281-285; 1989.
109. Othberg, A.; Keep, M.; Brundin, P.; Lindvall, O. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro. Exp. Neurol. 147: 498-502; 1997. [Erratum published in Exp. Neurol. 154: 260; 1998]
110. Pettmann, B.; Hendersen, C. E. Neuronal cell death. Neuron 20:633-647; 1998.
111. Pryor, W. A.; Squadrito, G. L. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:L699-L722; 1995.
112. Raff, M. C.; Barres, B. A.; Burne, J. F.; Coles, H. S.; Ishizaki, Y.; Jacobson, M. D. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-700; 1993.
113. Rosenblad, C.; Kirik, D.; Björklund, A. Neurturin enhance survival of intrastriatal fetal dopaminergic transplants. (Submitted).
114. Rosenblad, C.; Martinez-Serrano, A.; Björklund, A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75:979-985; 1996.
115. Sauer, H.; Brundin, P. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci. 2:123-135; 1991.
116. Sauer, H.; Fischer, W.; Nikkhah, G.; Wiegand, S. J.; Brundin, P.; Lindsay, R. M.; Björklund, A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 626:37-44; 1993.
117. Sautter, J.; Tseng, J. L.; Braguglia, D.; Aebischer, P.; Spenger, C.; Seiler, R. W.; Widmer, H. R.; Zurn, A. D. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol. 149:230-236; 1998.
118. Schierle, G. S.; Brundin, P. Excitotoxicity plays a role in the death of tyrosine hydroxylase-immunopositive nigral neurons cultured in serum-free medium. Exp. Neurol. 157:338-348; 1999.
119. Schierle, G. S.; Hansson, O.; Leist, M.; Nicotera, P.; Widner, H.; Brundin, P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5:97-100; 1999.
120. Schierle, G. S.; Karlsson, J.; Brundin, P. MK-801 treatment does not enhance the survival of grafted dopamine neurones. Neuroreport 9:1113-1116; 1998.
121. Schierle, G. S.; Leist, M.; Martinou, J. C.; Widner, H.; Nicotera, P.; Brundin, P. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur. J. Neurosci. 11:3073-3081; 1999.
122. Schmid-Elsaesser, R.; Hungerhuber, E.; Zausinger, S.; Baethmann, A.; Reulen, H. J. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia. Brain Res. 816:471-479; 1999.
123. Schmued, L. C.; Albertson, C.; Slikker, W., Jr. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751:37-46; 1997.
124. Schulz, J. B.; Henshaw, D. R.; Siwek, D.; Jenkins, B. G.; Ferrante, R. J.; Cipolloni, P. B.; Kowall, N. W.; Rosen, B. R.; Beal, M. F. Involvement of free radicals in excito-toxicity in vivo. J. Neurochem. 64:2239-2247; 1995.
125. Simonds, G. R.; Freed, W. J. Effects of intraventricular substantia nigra allografts as a function of donor age. Brain Res. 530:12-19; 1990.
126. Sinclair, S. R.; Fawcett, J. W.; Dunnett, S. B. Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery. Neuroreport 10:1263-1267; 1999.
127. Sinclair, S. R.; Svendsen, C. N.; Torres, E. M.; Martin, D.; Fawcett, J. W.; Dunnett, S. B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport 7:2547-2552; 1996.
128. Skulachev, V. P. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q. Rev. Biophys. 29: 169-202; 1996.
129. Sortwell, C. E.; Collier, T. J.; Sladek, J. R., Jr. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons. J. Comp. Neurol. 399:530-540; 1998.
130. Studer, L.; Spenger, C.; Seiler, R. W.; Altar, C. A.; Lindsay, R. M.; Hyman, C. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur. J. Neurosci. 7:223-233; 1995.
131. Sullivan, A. M.; Pohl, J.; Blunt, S. B. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. Eur. J. Neurosci. 10:3681-3688; 1998.
132. Swanson, L. W. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluoresence study in the rat. Brain Res. Bull. 9:321-412; 1982.
133. Szabo, C.; Day, B. J.; Salzman, A. L. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett. 381:82-86; 1996.
134. Tabbal, S.; Fahn, S.; Frucht, S. Fetal tissue transplantation in Parkinson's disease. Curr. Opin. Neurol. 11:341-349; 1998.
135. Takayama, H.; Ray, J.; Raymon, H. K.; Baird, A.; Hogg, J.; Fisher, L. J.; Gage, F. H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1:53-58; 1995.
136. Takei, M.; Hiramatsu, M.; Mori, A. Inhibitory effects of calcium antagonists on mitochondrial swelling induced by lipid peroxidation or arachidonic acid in the rat brain in vitro. Neurochem. Res. 19:1199-1206; 1994.
137. Tepper, J. M.; Damlama, M.; Trent, F. Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 60:469-477; 1994.
138. Thornberry, N. A.; Lazebnik, Y. Caspases: Enemies within. Science 281:1312-1316; 1998.
139. 2- channels. Naunyn Schmiedebergs Arch. Pharmacol. 337:690-692; 1988.
140. Van Muiswinkel, F. L.; Drukarch, B.; Steinbusch, H. W.; De Vente, J. Sustained pharmacological inhibition of nitric oxide synthase does not affect the survival of intrastriatal rat fetal mesencephalic transplants. Brain Res. 792:48-58; 1998.
141. Watts, C.; Caldwell, M. A.; Dunnett, S. B. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplant. 7:573-583; 1998.
142. Watts, C.; Hurelbrink, C.; Dunnett, S. B. The method of preparation of the donor tissue affects functional outcome in a rodent model of Parkinson's disease. Soc Neurosci. Abstr. 223.1. 1998.
143. Yakovlev, A. G.; Knoblach, S. M.; Fan, L.; Fox, G. B.; Goodnight, R.; Faden, A. I. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17:7415-7424; 1997.
144. Yang, L.; Matthews, R. T.; Schulz, J. B.; Klockgether, T.; Liao, A. W.; Martinou, J.-C.; Penney, J. B., Jr.; Hyman, B. T.; Beal, M. F. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity is attenuated in mice overexpressing bcl-2. J. Neurosci. 18:8145-8152; 1998.
145. Yue, T. L.; Gu, J. L.; Lysko, P. G.; Cheng, H. Y.; Barone, F. C.; Feuerstein, G. Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res. 574:193-197; 1992.
146. Yung, K. K. Localization of ionotropic and metabotropic glutamate receptors in distinct neuronal elements of the rat substantia nigra. Neurochem. Int. 33:313-326; 1998.
147. Yurek, D. M. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp. Neurol. 153:195-202; 1998.
148. Yurek, D. M.; Collier, T. J.; Sladek, J. R., Jr. Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:191-199; 1990.
149. Yurek, D. M.; Lu, W.; Hipkens, S.; Wiegand, S. J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:105-118; 1996.
150. Zawada, W. M.; Zastrow, D. J.; Clarkson, E. D.; Adams, F. S.; Bell, K. P.; Freed, C. R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:96-103; 1998.
151. Zeng, B. Y.; Jenner, P.; Marsden, C. D. Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferation. Exp. Neurol. 139:214-226; 1996.